Heart Disease
HighLife
To evaluate a new valve in patients with moderate-severe or severe mitral regurgitation and at high surgical risk.
Trial overview
Topic
Heart failure due to mitral valve regurgitation
Eligibility criteria
To be considered for this study you must meet the following criteria:
- 18 years of age or older
- Have moderate to severe mitral regurgitation
- Unable to undergo open heart surgery
Study details
Your participation in this study would be for approximately five years.
You will need to undergo a procedure to have the valve inserted and stay in hospital for up to 2-3 days. You will then be seen in the clinic at 30 days, 3 months, 6 months and 12 months and then annually up to 5 years. During these visits you will be asked about your health and medications and have a physical examination, blood test, ultrasound of your heart and ECG.
You will be reimbursed for travel and study-related expenses.
Further information
For further information regarding this clinical trial click here.
Location
Leabrook (Cardiology)
Wesley Hospital Auchenflower (Cardiology Consulting)
Murdoch (Cardiology)
North Shore (Cardiology)